申请人:Tanabe Seiyaku Co., Ltd.
公开号:US05206428A1
公开(公告)日:1993-04-27
A tetrahydronaphthalene derivative of the formula: ##STR1## wherein R.sup.1 is a substituted or unsubstituted phenyl group, naphthyl group, a sulfur- or nitrogen-containing heterocyclic group, a lower alkyl group or cycloalkyl group, and R.sup.2 is hydroxymethyl group, carboxyl group, a lower alkoxycarbonyl group or a group of the formula: ##STR2## wherein R.sup.3 is hydrogen atom or a lower alkyl group, R.sup.4 is a lower alkoxycarbonyl-phenyl group, carboxy-phenyl group, a lower alkyl group, a lower alkoxycarbonyl-lower alkyl group or carboxy-lower alkyl group, and m and n are different and are 1 or 2, or a pharmaceutically acceptable salt thereof, which are useful as a platelet aggregation-inhibiting agent and as an agent for the treatment, amelioration and/or prophylaxis of a variety of thrombosis or embolism, coronary and cerebral vascular smooth muscle vellication, asthma, and the like, processes for the preparation thereof, and pharmaceutical composition containing said compound as an active ingredient.
一种四氢萘衍生物,其化学式为:##STR1##其中R.sup.1是取代或未取代苯基,萘基,含硫或氮杂环基,低碳基或环烷基,R.sup.2是羟甲基基团,羧基,低碳基氧羧基基团或公式:##STR2##其中R.sup.3是氢原子或低碳基,R.sup.4是低碳基氧羧基苯基基团,羧基苯基基团,低碳基,低碳基氧羧基低碳基基团或羧基低碳基基团,m和n不同且均为1或2,或其药学上可接受的盐,可用作抑制血小板聚集的剂和治疗、改善和/或预防各种血栓或栓塞,冠状和脑血管平滑肌痉挛,哮喘等的药物,其制备过程以及含有该化合物作为活性成分的制药组合物。